Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 3462

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT02403869
Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Li…
Quality of Life in Metastatic Bre… Cancer À vérifier COMPLETED En attente / non publié Celgene Spain · Centro Médico Teknon, Barcelona, Spain | Comp… 2014-03-12 → 2019-01-31 Ouvrir
NCT01262677
Once-A-Day Pregabalin For Partial Seizures
pregabalin Épilepsie Phase 3 COMPLETED En attente / non publié Pfizer's Upjohn has merged with M… United States, Argentina, Bosnia and Herzegovina, Bul… 2011-02-17 → 2012-08-01 Ouvrir
NCT01486056
ECG Vector Determination
ECG Vector Determination Épilepsie À vérifier COMPLETED En attente / non publié Cyberonics, Inc. United States · Clinical Trials of Texas, Inc., San A… 2011-11 → 2012-01 Ouvrir
NCT05722951
Metformin Efficacy and Safety in Epileptic Patients
Levetiracetam &/or sodium valproa… Épilepsie Phase 3 COMPLETED En attente / non publié Tanta University Egypt · Omnia Ashraf Abd El Aziz Ahmed Kotb, Alexandr… 2022-10-18 → 2024-06-20 Ouvrir
NCT04677751
Clinical and Electrographic Changes in Responsive Neurostimulation Syst…
Acupuncture intervention Épilepsie NA RECRUITING En attente / non publié The University of Texas Health Sc… United States · The University of Texas Health Scienc… 2021-04-01 → 2025-12-01 Ouvrir
NCT05422339
Efficacy of Gamification in Enhancing User Engagement
The MapHabit system (MHS) Alzheimer NA COMPLETED En attente / non publié MapHabit, Inc. United States · MapHabit, Atlanta, United States 2022-09-12 → 2023-12-28 Ouvrir
NCT04309500
SHARE(D) Stage II: Alzheimer's Risk Disclosure Protocol Piloting
SHARE(D) Stage II: Alzheimer's Ri… Alzheimer NA COMPLETED En attente / non publié University of Michigan United States · University of Michigan Medical School… 2021-05-20 → 2022-01-31 Ouvrir
NCT05482867
Exploratory Open Label Study for Development of a Method To Detect Dend…
Exploratory Open Label Study for … Alzheimer À vérifier COMPLETED En attente / non publié MindImmune Therapeutics, Inc. United States · CNS, A Division of APEX Innovative Sc… 2022-11-28 → 2024-09-17 Ouvrir
NCT02085265
Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patien…
Perindopril Alzheimer Phase 2 TERMINATED En attente / non publié Sunnybrook Health Sciences Centre Canada · Baycrest Health Sciences, Toronto, Canada | … 2014-03 → 2025-02-28 Ouvrir
NCT02315781
tDCS in Parkinson's Disease With Depression
active tDCS Parkinson NA TERMINATED En attente / non publié Pacific Parkinson's Research Cent… Canada · Pacific Parkinson's Research Centre, Vancouv… 2015-01 → 2017-12-06 Ouvrir
NCT01684475
A STUDY TO EVALUATE THE EFFICACY OF CJH1 (CLR4001) IN PARKINSON'S DISEA…
CJH1 (CLR4001) Parkinson Phase 1 UNKNOWN En attente / non publié Alexandra Marine and General Hosp… Canada · Gateway Rural Health Research, Goderich, Can… 2012-09 → 2013-09 Ouvrir
NCT04044131
Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Park…
Metabolic Cofactor Supplementation Parkinson Phase 2 COMPLETED En attente / non publié Istanbul Medipol University Hospi… Turkey (Türkiye) · Alanya Alaaddin Keykubat Universit… 2019-12-02 → 2021-04-20 Ouvrir
NCT04017481
Non Invasive Neuromodulation for Patients With Motor Control Disorders
Non Invasive Neuromodulation for … Parkinson NA COMPLETED En attente / non publié Universidad Francisco de Vitoria Non communiqué 2016-09-01 → 2019-09-30 Ouvrir
NCT06464029
Pathways Mediating Impaired Postural Control in Parkinson's Disease
Pathways Mediating Impaired Postu… Parkinson À vérifier RECRUITING En attente / non publié University of Minnesota United States · University of Minnesota, Minneapolis,… 2024-06-01 → 2027-06-10 Ouvrir
NCT03574428
Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers
GNbAC1 SEP Phase 1 COMPLETED En attente / non publié GeNeuro Innovation SAS Australia · Scientia Clinical Research Ltd, Sydney, A… 2018-05-08 → 2018-11-02 Ouvrir
NCT02538094
tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis
Sham Transcranial direct current … SEP NA COMPLETED En attente / non publié The University of Texas at Dallas United States · Johns Hopkins East Baltimore Campus; … 2014-09 → 2019-06-30 Ouvrir
NCT03798366
A Clinical Study to Test How Effective and Safe GLPG1690 is for Partici…
GLPG1690 SEP Phase 2 COMPLETED En attente / non publié Lakefront Biotherapeutics NV United States, Belgium, Germany, Italy, Spain, United… 2019-01-14 → 2020-06-22 Ouvrir
NCT02601131
Post-transfusion Platelet Count
Platelet transfusion SEP À vérifier COMPLETED En attente / non publié Region Skane Sweden · Region Skåne, Lund, Sweden 2016-02 → 2016-09 Ouvrir
NCT05357781
Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With…
Immunoglobulin Deficiency a Treat… SEP À vérifier RECRUITING En attente / non publié Insel Gruppe AG, University Hospi… Switzerland · University Hospital of Bern Inselspital… 2022-07-01 → 2026-12-30 Ouvrir
NCT02874677
A Reeducation Program to Effort to Improve the Walking of Multiple Scle…
A Reeducation Program to Effort t… SEP NA TERMINATED En attente / non publié Lille Catholic University France · Centre Hospitalier Régional Universitaire de… 2017-12-07 → 2022-01-14 Ouvrir
NCT03088839
Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS)
Circulating Biomarker for Amyotro… Sclérose latérale amyotrophique À vérifier UNKNOWN En attente / non publié Neuromed IRCCS Italy · IRCCS Neuromed, Pozzilli, Italy 2017-12-01 → 2024-12-01 Ouvrir
NCT07118319
The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neur…
Human Allogeneic Induced Pluripot… Sclérose latérale amyotrophique Phase 1 RECRUITING En attente / non publié XellSmart Bio-Pharmaceutical (Suz… China · Peking University Third Hospital, Beijing, Ch… 2025-09-15 → 2028-09-30 Ouvrir
NCT00694941
A Phase II Multi-centre, Extension Study to Investigate the Long Term S…
ONO-2506PO Sclérose latérale amyotrophique Phase 2 COMPLETED En attente / non publié Ono Pharmaceutical Co., Ltd. Belgium, France, Germany, Italy, Netherlands, Switzer… 2008-06 Ouvrir
NCT06307301
Study in ALS With Abatacept & IL-2
Abatacept Injection [Orencia] and… Sclérose latérale amyotrophique Phase 1 COMPLETED En attente / non publié The Methodist Hospital Research I… United States · Houston Methodist Research Institute,… 2021-10-28 → 2023-12-31 Ouvrir
NCT01254539
Clinical Trial on The Use of Autologous Bone Marrow Stem Cells in Amyot…
Laminectomy and bone marrow stem … Sclérose latérale amyotrophique Phase 1 COMPLETED En attente / non publié Fundacion para la Formacion e Inv… Spain · Hospital Universitario Virgen de la Arrixaca,… 2010-10 → 2015-11-20 Ouvrir